Patent · US Active

Hybrid caulimovirus promoters and constructs thereof

US9856491B2 · kind B2 · utility

0Cited by
22References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2016
Grant dateJan 2, 2018
Priority date
Expiry dateApr 22, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A40/146
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to novel hybrid promoters comprising a caulimovirus promoter operably linked to one or more of an EF1α, Act8, Act2 or Act11 promoter. The present invention also relates to novel DNA constructs comprising at least one expression cassette which comprises the hybrid promoter thereof. The present invention further relates to transgenic plants/seeds comprising such DNA constructs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.